Of all the factors released during bone resorption, matrix-derived growth factors can aid tumor cell survival and/or PTHrP production (43), feeding the cycle of osteolysis and thus, investigating the CaSR-PTHrP axis might open doors on a therapeutic front. This evidence concerns the gene PTHLH and neoplasm.